Literature DB >> 15687

[Adrenergic component in the hepatotropic, carcinogenic effect of diethylnitrosamine].

V K Gurkalo, M A Zabezhinskiĭ, G B Pliss, S S Krylov.   

Abstract

The effect of norepinephine, an adrenomietic drug, and of pyrroxane, its antagonist, on diethylnitrosoamine (DENA) hepatocarcinogenesis was studied in albino rats. Norepinephrine was found to stimulate carcinogenesis, whereas pyrroxane--to inhibit this process; the latter drug decreased the incidence of multicentric tumours of the liver. In vitro experiments on the isolated rat atria showed low DENA concentrations (1x10(-6) to 1x10(-8) M) to sensitize the atrium adrenoreceptors to the endogenous and exogenous norepinephrine. A new hypothesis on the adrenergic component in the DENA carcinogenic effect caused by the endogenous norepinephrine is presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 15687

Source DB:  PubMed          Journal:  Biull Eksp Biol Med        ISSN: 0365-9615


  2 in total

1.  Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer.

Authors:  Paul J Fitzgerald
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

2.  Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint.

Authors:  Paul J Fitzgerald
Journal:  Clin Epidemiol       Date:  2012-06-29       Impact factor: 4.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.